Effect of synthesized constituents in the L-tryptophan product on the differentiation of eosinophils and the induction of IL-6: A possible cause of eosinophilia-myalgia syndrome
- 1 August 1991
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 178 (3) , 1008-1013
- https://doi.org/10.1016/0006-291x(91)90992-g
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Characterization of "Peak E," a Novel Amino Acid Associated with Eosinophilia-Myalgia SyndromeScience, 1990
- L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.Journal of Clinical Investigation, 1990
- An Investigation of the Cause of the Eosinophilia–Myalgia Syndrome Associated with Tryptophan UseNew England Journal of Medicine, 1990
- The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan IngestionAnnals of Internal Medicine, 1990
- Scleroderma, Fasciitis, and Eosinophilia Associated with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Association of the Eosinophilia–Myalgia Syndrome with the Ingestion of TryptophanNew England Journal of Medicine, 1990
- Tryptophan-Associated Eosinophilic Connective-Tissue DiseaseJAMA, 1990
- Development of Diffuse Fasciitis with Eosinophilia during L-Tryptophan Treatment: Demonstration of Elevated Type I Collagen Gene Expression in Affected TissuesAnnals of Internal Medicine, 1990
- Eosinophilia/myalgia syndrome associated with L-tryptophanThe Lancet, 1990
- Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritisEuropean Journal of Immunology, 1988